Takeda Vaccines, Inc.

Q3 2025 13F Notice

Signature - Title
Max Heuer - Authorized Signatory
Location
Cambridge, MA
Holdings as of
30 Sep 2025
Filing time
13 Nov 2025, 07:58:43 UTC
Form type
13F-NT
Description
No holdings are reported in this report, and all US holdings are reported by other reporting manager(s). Top holdings included .
SEC
View on sec.gov

Takeda Vaccines, Inc. didn't report any stock holdings as of Q3 2025.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Max Heuer Authorized Signatory Cambridge, Massachusetts 13 Nov 2025

TAKEDA PHARMACEUTICAL CO LTD is reporting for Takeda Vaccines, Inc.:

Name Holdings Value Location File Number
TAKEDA PHARMACEUTICAL CO LTD $16,369,175 Tokyo, Japan 028-24938